U.S. markets closed

Acceleron Pharma Inc. (XLRN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
117.75+4.00 (+3.52%)
At close: 1:00PM EST

117.75 0.00 (0.00%)
After hours: 1:15PM EST

Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Premium required to access monthly data
Subscribe to Premium to download historical data
As of Date: 11/27/2020
Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 6

Trading Information

Stock Price History

Beta (5Y Monthly) 0.52
52-Week Change 3132.33%
S&P500 52-Week Change 315.56%
52 Week High 3124.01
52 Week Low 346.00
50-Day Moving Average 3112.55
200-Day Moving Average 3102.92

Share Statistics

Avg Vol (3 month) 3326.4k
Avg Vol (10 day) 3203.2k
Shares Outstanding 560.25M
Float 52.95M
% Held by Insiders 112.09%
% Held by Institutions 190.28%
Shares Short (Nov 12, 2020) 43.51M
Short Ratio (Nov 12, 2020) 412.15
Short % of Float (Nov 12, 2020) 47.74%
Short % of Shares Outstanding (Nov 12, 2020) 45.82%
Shares Short (prior month Oct 14, 2020) 43.92M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Sep 29, 2020


Profit Margin -124.73%
Operating Margin (ttm)-127.64%

Management Effectiveness

Return on Assets (ttm)-11.52%
Return on Equity (ttm)-19.44%

Income Statement

Revenue (ttm)105.99M
Revenue Per Share (ttm)1.93
Quarterly Revenue Growth (yoy)436.10%
Gross Profit (ttm)-79.96M
EBITDA -131.44M
Net Income Avi to Common (ttm)-132.21M
Diluted EPS (ttm)-2.40
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)882.36M
Total Cash Per Share (mrq)14.65
Total Debt (mrq)21.85M
Total Debt/Equity (mrq)2.44
Current Ratio (mrq)24.50
Book Value Per Share (mrq)14.91

Cash Flow Statement

Operating Cash Flow (ttm)-108.45M
Levered Free Cash Flow (ttm)-66.5M